Recon: CMS to restrict coverage of Aduhelm to only clinical trials; FDA warns of dental issues with buprenorphine

ReconReconBiologicsBiotechnologyDiagnosticsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy